TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 1.45 Delayed Data As of 3:29pm ET |  +0.05 / +3.57%Today’s Change | 0.82 Today|||52-Week Range 3.88 | +45.17% Year-to-Date |
Latest TCRR News | Press Releases
No recent news for TCR2 Therapeutics Inc.
Today’s Trading
| Previous close | 1.40 |
| Today’s open | 1.44 |
| Day’s range | 1.44 - 1.50 |
| Volume | 1,318 |
| Average volume (3 months) | 287,261 |
| Market cap | $54.5M |
Data as of 3:29pm ET, 01/31/2023
Growth & Valuation
| Earnings growth (last year) | -9.71% |
| Earnings growth (this year) | -18.49% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.19 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HOOKHOOKIPA Pharma Inc | +0.00 | +0.02% |
| INFIInfinity Pharmaceuti... | +0.01 | +1.15% |
| ---- | ||
| ---- |
Data as of 3:32pm ET, 01/31/2023
Financials
| Next reporting date | April 3, 2023 |
| EPS forecast (this quarter) | -$0.82 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$99.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
